236 — Bedford, Texas

236 is a clinical research site located in Bedford, Texas, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

236 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bedford

Browse all research sites in Texas · View every site in Bedford

• Texas Health Harris Methodist Hospital Hurst-Euless-Bedford
• Texas Oncology Bedford 1609 Hospital Parkway
• Texas Health Harris Methodist Hurst-Euless-Bedford Hospital
• Texas Oncology Bedford
• Texas Oncology P A
• Research Site
• GSK Investigational Site
• Texas Oncology
• Center for Assisted Reproduction
• Texas Oncology P A Bedford
• Pfizer Investigational Site
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 236?

236 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 236 conducted?

236 has 1 clinical trials on record. Their work covers Epilepsy.

Is 236 accredited by Crixeo Clinical Trials?

236 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 236?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.